Growth Metrics

Microbot Medical (MBOT) FCF Margin (2016)

Historic FCF Margin for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to 1285.03%.

  • Microbot Medical's FCF Margin rose 195486600.0% to 1285.03% in Q3 2016 from the same period last year, while for Dec 2016 it was 951.46%, marking a year-over-year decrease of 2967900.0%. This contributed to the annual value of 656.19% for FY2015, which is N/A changed from last year.
  • As of Q3 2016, Microbot Medical's FCF Margin stood at 1285.03%, which was up 195486600.0% from 213.23% recorded in Q2 2016.
  • Over the past 5 years, Microbot Medical's FCF Margin peaked at 82719.06% during Q4 2015, and registered a low of 43477.63% during Q1 2015.
  • Moreover, its 5-year median value for FCF Margin was 8437.74% (2014), whereas its average is 8232.52%.
  • Per our database at Business Quant, Microbot Medical's FCF Margin tumbled by -198110400bps in 2013 and then skyrocketed by 834775400bps in 2015.
  • Microbot Medical's FCF Margin (Quarter) stood at 2356.82% in 2012, then crashed by -561bps to 15587.14% in 2013, then skyrocketed by 95bps to 758.48% in 2014, then surged by 11006bps to 82719.06% in 2015, then plummeted by -102bps to 1285.03% in 2016.
  • Its last three reported values are 1285.03% in Q3 2016, 213.23% for Q2 2016, and 1290.51% during Q1 2016.